Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Managing Functional Disturbances in Patients with Inflammatory Bowel Disease.

Current treatment options in gastroenterology

Ginsburg PM, Bayless TM.
PMID: 15913510
Curr Treat Options Gastroenterol. 2005 Jun;8(3):211-221. doi: 10.1007/s11938-005-0013-0.

Functional disturbances occur in approximately 10% to 15% of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions...

Cite
Ginsburg PM, Bayless TM. Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2005;8(3):211-221doi: 10.1007/s11938-005-0013-0.
Ginsburg, P. M., & Bayless, T. M. (2005). Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Current treatment options in gastroenterology, 8(3), 211-221. https://doi.org/10.1007/s11938-005-0013-0
Ginsburg, Philip M, and Bayless, Theodore M. "Managing Functional Disturbances in Patients with Inflammatory Bowel Disease." Current treatment options in gastroenterology vol. 8,3 (2005): 211-221. doi: https://doi.org/10.1007/s11938-005-0013-0
Ginsburg PM, Bayless TM. Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2005 Jun;8(3):211-221. doi: 10.1007/s11938-005-0013-0. PMID: 15913510.
Copy Download .nbib Format: NLM
Short bowel syndrome.

Current treatment options in gastroenterology

Parekh NR, Steiger E.
PMID: 17298760
Curr Treat Options Gastroenterol. 2007 Feb;10(1):10-23. doi: 10.1007/s11938-007-0052-9.

Treatment of short bowel syndrome (SBS) is often a difficult endeavor due to the high variability among patients with SBS in regard to remaining anatomical structure and functional capacity. Research efforts to substantiate the use of existing therapies in...

Cite
Parekh NR, Steiger E. Short bowel syndrome. Curr Treat Options Gastroenterol. 2007;10(1):10-23doi: 10.1007/s11938-007-0052-9.
Parekh, N. R., & Steiger, E. (2007). Short bowel syndrome. Current treatment options in gastroenterology, 10(1), 10-23. https://doi.org/10.1007/s11938-007-0052-9
Parekh, Neha R, and Steiger, Ezra. "Short bowel syndrome." Current treatment options in gastroenterology vol. 10,1 (2007): 10-23. doi: https://doi.org/10.1007/s11938-007-0052-9
Parekh NR, Steiger E. Short bowel syndrome. Curr Treat Options Gastroenterol. 2007 Feb;10(1):10-23. doi: 10.1007/s11938-007-0052-9. PMID: 17298760.
Copy Download .nbib Format: NLM
Irritable bowel syndrome: current and emerging treatment options.

P & T : a peer-reviewed journal for formulary management

Peyton L, Greene J.
PMID: 25136255
P T. 2014 Aug;39(8):567-78.

Irritable bowel syndrome, a functional gastrointestinal disorder of uncertain pathophysiology, affects up to 55 million Americans. Medications available or in development include antispasmodics, antidepressants, and antidiarrheals.

Cite
Peyton L, Greene J. Irritable bowel syndrome: current and emerging treatment options. P T. 2014;39(8):567-78
Peyton, L., & Greene, J. (2014). Irritable bowel syndrome: current and emerging treatment options. P & T : a peer-reviewed journal for formulary management, 39(8), 567-78.
Peyton, Lauren, and Greene, Joy. "Irritable bowel syndrome: current and emerging treatment options." P & T : a peer-reviewed journal for formulary management vol. 39,8 (2014): 567-78.
Peyton L, Greene J. Irritable bowel syndrome: current and emerging treatment options. P T. 2014 Aug;39(8):567-78. PMID: 25136255; PMCID: PMC4123807.
Copy Download .nbib Format: NLM
Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria.

Pharmacy practice

Ogbo PU, Aina BA, Aderemi-Williams RI.
PMID: 24644521
Pharm Pract (Granada). 2014 Jan;12(1):376. doi: 10.4321/s1886-36552014000100002. Epub 2014 Mar 24.

BACKGROUND: Acute diarrhea in children leads to dehydration and death if not appropriately managed. World Health Organization (WHO) recommends treating diarrhea with oral rehydration therapy (ORT), fluids and foods. Proper management is hinged on accurate assessment of patients to...

Cite
Ogbo PU, Aina BA, Aderemi-Williams RI. Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria. Pharm Pract (Granada). 2014;12(1):376doi: 10.4321/s1886-36552014000100002.
Ogbo, P. U., Aina, B. A., & Aderemi-Williams, R. I. (2014). Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria. Pharmacy practice, 12(1), 376. https://doi.org/10.4321/s1886-36552014000100002
Ogbo, Patricia U, et al. "Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria." Pharmacy practice vol. 12,1 (2014): 376. doi: https://doi.org/10.4321/s1886-36552014000100002
Ogbo PU, Aina BA, Aderemi-Williams RI. Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria. Pharm Pract (Granada). 2014 Jan;12(1):376. doi: 10.4321/s1886-36552014000100002. Epub 2014 Mar 24. PMID: 24644521; PMCID: PMC3955866.
Copy Download .nbib Format: NLM
Overcoming Runner's Diarrhea.

The Physician and sportsmedicine

Sullivan SN.
PMID: 29286893
Phys Sportsmed. 1992 Oct;20(10):63-68. doi: 10.1080/00913847.1992.11947502.

In brief Many people experience bowel dysfunction related to running, ranging from prerace 'nervous diarrhea' to bloody diarrhea after an exhausting run. Potential causes vary. Diagnosis rests on an accurate history and selective investigation to exclude disease. Treatment may...

Cite
Sullivan SN. Overcoming Runner's Diarrhea. Phys Sportsmed. 1992;20(10):63-68doi: 10.1080/00913847.1992.11947502.
Sullivan, S. N. (1992). Overcoming Runner's Diarrhea. The Physician and sportsmedicine, 20(10), 63-68. https://doi.org/10.1080/00913847.1992.11947502
Sullivan, Stephen N. "Overcoming Runner's Diarrhea." The Physician and sportsmedicine vol. 20,10 (1992): 63-68. doi: https://doi.org/10.1080/00913847.1992.11947502
Sullivan SN. Overcoming Runner's Diarrhea. Phys Sportsmed. 1992 Oct;20(10):63-68. doi: 10.1080/00913847.1992.11947502. PMID: 29286893.
Copy Download .nbib Format: NLM
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).

International journal of MS care

Fox EJ, Vasquez A, Grainger W, Ma TS, von Hehn C, Walsh J, Li J, Zambrano J.
PMID: 26917993
Int J MS Care. 2016 Jan-Feb;18(1):9-18. doi: 10.7224/1537-2073.2014-101.

BACKGROUND: In phase 3 trials, delayed-release dimethyl fumarate (DMF; also known as gastroresistant DMF) demonstrated efficacy in relapsing-remitting multiple sclerosis (MS). Gastrointestinal (GI) events were associated with DMF treatment. The single-arm, open-label MANAGE study examined the incidence, severity, duration,...

Cite
Fox EJ, Vasquez A, Grainger W, et al. Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE). Int J MS Care. 2016;18(1):9-18doi: 10.7224/1537-2073.2014-101.
Fox, E. J., Vasquez, A., Grainger, W., Ma, T. S., von Hehn, C., Walsh, J., Li, J., & Zambrano, J. (2016). Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE). International journal of MS care, 18(1), 9-18. https://doi.org/10.7224/1537-2073.2014-101
Fox, Edward J, et al. "Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)." International journal of MS care vol. 18,1 (2016): 9-18. doi: https://doi.org/10.7224/1537-2073.2014-101
Fox EJ, Vasquez A, Grainger W, Ma TS, von Hehn C, Walsh J, Li J, Zambrano J. Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE). Int J MS Care. 2016 Jan-Feb;18(1):9-18. doi: 10.7224/1537-2073.2014-101. PMID: 26917993; PMCID: PMC4766951.
Copy Download .nbib Format: NLM
Acute Infectious Diarrhea and Gastroenteritis in Children.

Current infectious disease reports

Florez ID, Niño-Serna LF, Beltrán-Arroyave CP.
PMID: 31993758
Curr Infect Dis Rep. 2020 Jan 28;22(2):4. doi: 10.1007/s11908-020-0713-6.

PURPOSE OF REVIEW: We aimed to summarize the most current evidence on the main aspects of the diarrheal diseases in children. The following key elements were addressed: definitions, etiology, pathogenesis, diagnosis, dietary management, pharmacological treatments, and prevention. We covered...

Cite
Florez ID, Niño-Serna LF, Beltrán-Arroyave CP. Acute Infectious Diarrhea and Gastroenteritis in Children. Curr Infect Dis Rep. 2020;22(2):4doi: 10.1007/s11908-020-0713-6.
Florez, I. D., Niño-Serna, L. F., & Beltrán-Arroyave, C. P. (2020). Acute Infectious Diarrhea and Gastroenteritis in Children. Current infectious disease reports, 22(2), 4. https://doi.org/10.1007/s11908-020-0713-6
Florez, Ivan D, et al. "Acute Infectious Diarrhea and Gastroenteritis in Children." Current infectious disease reports vol. 22,2 (2020): 4. doi: https://doi.org/10.1007/s11908-020-0713-6
Florez ID, Niño-Serna LF, Beltrán-Arroyave CP. Acute Infectious Diarrhea and Gastroenteritis in Children. Curr Infect Dis Rep. 2020 Jan 28;22(2):4. doi: 10.1007/s11908-020-0713-6. PMID: 31993758.
Copy Download .nbib Format: NLM
Irritable bowel syndrome: diagnosis and management.

Minerva gastroenterologica e dietologica

Masuy I, Pannemans J, Tack J.
PMID: 31820883
Minerva Gastroenterol Dietol. 2020 Jun;66(2):136-150. doi: 10.23736/S1121-421X.19.02640-0. Epub 2019 Dec 09.

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders (FGIDs) encountered in clinical practice. In the absence of an accurate biomarker for the disorder, IBS is mainly diagnosed based symptomology using the Rome criteria. Due...

Cite
Masuy I, Pannemans J, Tack J. Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterol Dietol. 2019;66(2):136-150doi: 10.23736/S1121-421X.19.02640-0.
Masuy, I., Pannemans, J., & Tack, J. (2020). Irritable bowel syndrome: diagnosis and management. Minerva gastroenterologica e dietologica, 66(2), 136-150. https://doi.org/10.23736/S1121-421X.19.02640-0
Masuy, Imke, et al. "Irritable bowel syndrome: diagnosis and management." Minerva gastroenterologica e dietologica vol. 66,2 (2020): 136-150. doi: https://doi.org/10.23736/S1121-421X.19.02640-0
Masuy I, Pannemans J, Tack J. Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterol Dietol. 2020 Jun;66(2):136-150. doi: 10.23736/S1121-421X.19.02640-0. Epub 2019 Dec 09. PMID: 31820883.
Copy Download .nbib Format: NLM
I, 5. Treatment of viral gastroenteritis.

Perspectives in medical virology

Bass D.
PMID: 32287600
Perspect Med Virol. 2003;9:93-104. doi: 10.1016/S0168-7069(03)09006-2. Epub 2004 Sep 14.

Viral gastroenteritis (mainly after rotavirus infection) directly causes death through dehydration. Thus, the treatment and prevention of dehydration are the primary goals in caring for infants with gastroenteritis. Viral gastroenteritis can also inflict considerable nutritional insult on children because...

Cite
Bass D. I, 5. Treatment of viral gastroenteritis. Perspect Med Virol. 2004;9:93-104doi: 10.1016/S0168-7069(03)09006-2.
Bass, D. (2003). I, 5. Treatment of viral gastroenteritis. Perspectives in medical virology, 993-104. https://doi.org/10.1016/S0168-7069(03)09006-2
Bass, Dorsey. "I, 5. Treatment of viral gastroenteritis." Perspectives in medical virology vol. 9 (2003): 93-104. doi: https://doi.org/10.1016/S0168-7069(03)09006-2
Bass D. I, 5. Treatment of viral gastroenteritis. Perspect Med Virol. 2003;9:93-104. doi: 10.1016/S0168-7069(03)09006-2. Epub 2004 Sep 14. PMID: 32287600; PMCID: PMC7134010.
Copy Download .nbib Format: NLM
Anal and Perineal Injuries.

Clinics in colon and rectal surgery

Jeganathan AN, Cannon JW, Bleier JIS.
PMID: 29379404
Clin Colon Rectal Surg. 2018 Jan;31(1):24-29. doi: 10.1055/s-0037-1602176. Epub 2017 Dec 19.

With increased use of explosive devices in warfare, anal trauma is often seen coupled with more complex pelviperineal injury. While the associated mortality is high, casualties that survive are often left with disabling fecal incontinence from damage to the...

Cite
Jeganathan AN, Cannon JW, Bleier JIS. Anal and Perineal Injuries. Clin Colon Rectal Surg. 2017;31(1):24-29doi: 10.1055/s-0037-1602176.
Jeganathan, A. N., Cannon, J. W., & Bleier, J. I. S. (2018). Anal and Perineal Injuries. Clinics in colon and rectal surgery, 31(1), 24-29. https://doi.org/10.1055/s-0037-1602176
Jeganathan, Arjun N, et al. "Anal and Perineal Injuries." Clinics in colon and rectal surgery vol. 31,1 (2018): 24-29. doi: https://doi.org/10.1055/s-0037-1602176
Jeganathan AN, Cannon JW, Bleier JIS. Anal and Perineal Injuries. Clin Colon Rectal Surg. 2018 Jan;31(1):24-29. doi: 10.1055/s-0037-1602176. Epub 2017 Dec 19. PMID: 29379404; PMCID: PMC5787399.
Copy Download .nbib Format: NLM
Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication.

Journal of travel medicine

Handschin JC, Steffen R, Stürchler D, Wall M.
PMID: 9815496
J Travel Med. 1997 Sep 01;4(3):121-127. doi: 10.1111/j.1708-8305.1997.tb00798.x.

Background: To determine the relevance of drug interactions with co-medication for effectiveness and tolerability of antimalarial chemoprophylaxis. Method: A database (MALPRO2) on travelers on their flight home from Africa to Europe between July 1988 and December 1991 was reanalyzed....

Cite
Handschin JC, Steffen R, Stürchler D, et al. Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication. J Travel Med. 1997;4(3):121-127doi: 10.1111/j.1708-8305.1997.tb00798.x.
Handschin, J. C., Steffen, R., Stürchler, D., & Wall, M. (1997). Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication. Journal of travel medicine, 4(3), 121-127. https://doi.org/10.1111/j.1708-8305.1997.tb00798.x
Handschin, et al. "Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication." Journal of travel medicine vol. 4,3 (1997): 121-127. doi: https://doi.org/10.1111/j.1708-8305.1997.tb00798.x
Handschin JC, Steffen R, Stürchler D, Wall M. Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication. J Travel Med. 1997 Sep 01;4(3):121-127. doi: 10.1111/j.1708-8305.1997.tb00798.x. PMID: 9815496.
Copy Download .nbib Format: NLM
Functional Anorectal Disorders.

Gastroenterology

Rao SS, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, Wald A.
PMID: 27144630
Gastroenterology. 2016 Mar 25; doi: 10.1053/j.gastro.2016.02.009. Epub 2016 Mar 25.

This report defines criteria and reviews the epidemiology, pathophysiology, and management of common anorectal disorders: fecal incontinence (FI), functional anorectal pain and functional defecation disorders. FI is defined as the recurrent uncontrolled passage of fecal material for at least...

Cite
Rao SS, Bharucha AE, Chiarioni G, et al. Functional Anorectal Disorders. Gastroenterology. 2016;doi: 10.1053/j.gastro.2016.02.009.
Rao, S. S., Bharucha, A. E., Chiarioni, G., Felt-Bersma, R., Knowles, C., Malcolm, A., & Wald, A. (2016). Functional Anorectal Disorders. Gastroenterology, . https://doi.org/10.1053/j.gastro.2016.02.009
Rao, Satish Sc, et al. "Functional Anorectal Disorders." Gastroenterology vol. (2016). doi: https://doi.org/10.1053/j.gastro.2016.02.009
Rao SS, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, Wald A. Functional Anorectal Disorders. Gastroenterology. 2016 Mar 25; doi: 10.1053/j.gastro.2016.02.009. Epub 2016 Mar 25. PMID: 27144630; PMCID: PMC5035713.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries